Updates in Endoscopic Bariatric and Metabolic Therapies.
Hammad QureshiNaba SaeedManol JovaniPublished in: Journal of clinical medicine (2023)
The rising prevalence of obesity, and related morbidity and mortality, has necessitated the development of therapeutic weight loss strategies. Lifestyle modifications alone have only yielded modest benefit, and while bariatric surgery has shown significant short- and long-term results, only a minority of eligible patients end up receiving this treatment. Endoscopic bariatric and metabolic therapies (EBMTs) are a rapidly evolving field, which provides a less invasive middle ground treatment option for weight loss. Here we discuss the efficacy, as well as short- and long-term outcomes with restrictive, malabsorptive/metabolic and aspiration endoscopic techniques, and their effects on metabolic parameters.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- ultrasound guided
- gastric bypass
- obese patients
- end stage renal disease
- glycemic control
- metabolic syndrome
- chronic kidney disease
- newly diagnosed
- weight gain
- ejection fraction
- type diabetes
- physical activity
- body mass index
- risk factors
- cardiovascular disease
- prognostic factors
- insulin resistance
- endoscopic submucosal dissection
- skeletal muscle
- high fat diet induced
- replacement therapy